A higher staining score for SLC7A9 in tumour tissues was correlated with rapid tumour recurrence (p = 0.0203, chi-square test) and an advanced TNM stage (p = 0.002, chi-square test), which indicated that SLC7A9 promoted resistance to chemotherapy and the progression of gastric cancer. This evidence concerns the gene SLC7A9 and neoplasm.